Welcome to LookChem.com Sign In|Join Free

CAS

  • or
4-ethyl-N-(3-methylphenyl)benzamide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

313537-28-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 313537-28-9 Structure
  • Basic information

    1. Product Name: 4-ethyl-N-(3-methylphenyl)benzamide
    2. Synonyms: 4-ethyl-N-(3-methylphenyl)benzamide
    3. CAS NO:313537-28-9
    4. Molecular Formula: C16H17NO
    5. Molecular Weight: 239.31228
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 313537-28-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 4-ethyl-N-(3-methylphenyl)benzamide(CAS DataBase Reference)
    10. NIST Chemistry Reference: 4-ethyl-N-(3-methylphenyl)benzamide(313537-28-9)
    11. EPA Substance Registry System: 4-ethyl-N-(3-methylphenyl)benzamide(313537-28-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 313537-28-9(Hazardous Substances Data)

313537-28-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 313537-28-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,3,5,3 and 7 respectively; the second part has 2 digits, 2 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 313537-28:
(8*3)+(7*1)+(6*3)+(5*5)+(4*3)+(3*7)+(2*2)+(1*8)=119
119 % 10 = 9
So 313537-28-9 is a valid CAS Registry Number.

313537-28-9Downstream Products

313537-28-9Relevant articles and documents

Synthesis of Secondary Amides through the Palladium(II)-Catalyzed Aminocarbonylation of Arylboronic Acids with Amines or Hydrazines and Carbon Dioxide

Zhang, Jin,Ma, Yuqiang,Ma, Yangmin

supporting information, p. 1720 - 1725 (2018/04/24)

A new Pd-catalyzed aminocarbonylation of arylboronic acids with amines or phenylhydrazines has been developed. Various secondary amides were produced from readily available substrates and cheap common metal catalysts in a CO atmosphere (balloon). Remarkably, we presents the first example of aminocarbonylations between arylboronic acids and phenylhydrazines.

Method for synthesizing N-aryl aromatic amide by adopting aromatic hydrazine

-

Paragraph 0094-0097, (2018/03/26)

The invention discloses a method for synthesizing N-aryl aromatic amide by adopting aromatic hydrazine. The method includes that arylboronic acid, the aromatic hydrazine, a primary catalyst and an auxiliary catalyst are added in a solvent, the N-aryl aromatic amide as is indicated in the formula III is obtained by performing separation and purification after heating reflux reaction, and CO is fedto a reaction to enable pressure of the reaction system to be 0.1-5MPa during reaction. The method is concise and efficient, phenylhydrazine is substituted, organic boronic acid and CO which are stable in air and easy to obtain are taken as raw materials, metal palladium is taken as the primary catalyst, copper or iron is taken as the auxiliary catalyst, and the N-aryl aromatic amide is synthesized efficiently under mild reaction conditions.

NOVEL BIARYLAMIDE DERIVATIVE AND COMPOSITIONS CONTAINING THE DERIVATIVE AS AN ACTIVE INGREDIENT

-

Page/Page column 9, (2012/12/13)

The present invention relates to a novel biarylamide derivative and a pharmaceutical composition or a cosmetic composition comprising the same as an active ingredient. More particularly, the present invention relates to a novel biarylamide derivative, a pharmaceutical composition or a cosmetic composition for preventing or treating a pigmentation disorder caused by an abnormal excess of melanin or a disease caused by melanocyte hyperplasia comprising the same as an active ingredient. The biarylamide derivative of the present invention inhibits melanin production and thus inhibits melanocyte hyperplasia. Therefore, a cosmetic composition comprising the biarylamide is excellent in a whitening effect, and a pharmaceutical composition comprising the biarylamide is effective in the prevention or treatment of pigmentation disorders of skin such as lentigo, melasma, freckle, etc. and malignant melanoma.

Identification of a potent and noncytotoxic inhibitor of melanin production

Hwang, Soonho,Choi, Sang Yoon,Lee, Jin Hee,Kim, Shinae,In, Jinkyung,Ha, Sang Keun,Lee, Eunjung,Kim, Tae-Yoon,Kim, Sun Yeou,Choi, Sun,Kim, Sanghee

experimental part, p. 5602 - 5609 (2010/09/14)

On the basis of a hit from random screening, biaryl amide derivatives were prepared in a combinatorial manner via parallel solution-phase synthesis, and their effects on melanocytes were investigated to discover new effective skin depigmenting agents. Amo

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 313537-28-9